SCHEMBL3574590

SCHEMBL3574590

O=C(NC1CCCCC1)C1=C(c2ccccc2)c2ccc(OCCN3CCOCC3)cc2C1=O

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.73
BMPR1B O00238 1/20 0.53
BMPR1A P36894 1/20 0.53
TGFBR1 P36897 1/20 0.53
ACVRL1 P37023 1/20 0.53
ACVR1 Q04771 1/20 0.53
EPHX2 P34913 2/20 0.51
ADORA3 P0DMS8 1/20 0.49
ADORA2A P29274 1/20 0.49
ADORA2B P29275 1/20 0.49
ADORA1 P30542 1/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
HRH3 Q9Y5N1 1/20 0.47
CNR2 P34972 4/20 0.47
CNR1 P21554 3/20 0.47
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4823811 0.96 PPARG (0.68) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL4889178 0.93 PPARG (0.64) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL3569658 0.90 PPARG (0.70) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL3569656 0.90 PPARG (0.70) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL13316081 0.89 PPARG (0.92) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL13316096 0.84 PPARG (1.00) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL3572485 0.83 PPARG (0.61) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
SCHEMBL3577620 0.83 PPARG (0.62) PPARGEPHX2KDM4E
SCHEMBL3569503 0.81 PPARG (0.60) PPARGBMPR1BBMPR1ATGFBR1ACVRL1
Isopropylamine SCHEMBL3580363 0.80 PPARG (0.65) PPARGADORA3ADORA2AADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745439-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-29 US disclosed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof INSR, GPR119, PPARA PPARG 8/4885BMPR1B 835/4885BMPR1A 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.